SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 13th, 2024 • First Wave BioPharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 13th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 10, 2024, between First Wave BioPharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT FIRST WAVE BIOPHARMA, INC.Pre-Funded Common Stock Purchase Warrant • May 13th, 2024 • First Wave BioPharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 13th, 2024 Company Industry JurisdictionTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from First Wave BioPharma, Inc. a Delaware corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT FIRST WAVE BIOPHARMA, INC.Common Stock Purchase Warrant • May 13th, 2024 • First Wave BioPharma, Inc. • Pharmaceutical preparations
Contract Type FiledMay 13th, 2024 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 14, 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 14, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from First Wave BioPharma, Inc. a Delaware corporation (the “Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 13th, 2024 • First Wave BioPharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 13th, 2024 Company Industry Jurisdiction